4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001649904-26-000026
President and CEO sold 50,000 shares at an average $102.67 ($5,133,442)
- President and CEO acquired 50,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Meeker David P · President and CEO
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-14 | Exercise or conversion : show line 1 in the form 10b5-1 | +50,000 | $6.05 | $302,500 | 289,258 | D |
| 2026-09-14 | Sale : show line 2 in the form 10b5-1 | −6,439 | $101.75 | $655,145 | 282,819 | D |
| 2026-09-14 | Sale : show line 3 in the form 10b5-1 | −30,746 | $102.35 | $3,146,761 | 252,073 | D |
| 2026-09-14 | Sale : show line 4 in the form 10b5-1 | −8,698 | $103.43 | $899,634 | 243,375 | D |
| 2026-09-14 | Sale : show line 5 in the form 10b5-1 | −1,817 | $104.55 | $189,965 | 241,558 | D |
| 2026-09-14 | Sale : show line 6 in the form 10b5-1 | −2,300 | $105.19 | $241,937 | 239,258 | D |
| Open-market sales · 50,000 sh · avg $102.67 · $5,133,442 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-09-14 | Exercise or conversion : show line 7 in the form 10b5-1 Employee Stock Option (Right to Buy) | −50,000 | 15,431 | D |
Loading xslF345X06/form4.xml…